6550--Ioflupane - Brand Name or Equal

The Department of Veterans Affairs Network Contracting Office 4 is seeking a contractor to provide radiopharmaceutical isotopes, specifically I-123 Ioflupane (DaTscan), for the Nuclear Medicine Department at the Philadelphia VA Medical Center. The solicitation is for a firm-fixed-price contract with one base year and four option years, running from January 17, 2025 through January 16, 2030. Potential contractors must be licensed by the Nuclear Regulatory Commission and capable of providing daily delivery of unit doses by 8:00 AM, with emergency delivery possible within 45 minutes. The evaluation will prioritize technical capability and past performance over price, with key requirements including proper radioactive material labeling and electronic dose tracking systems. Important dates include a January 7, 2025 deadline for submitting questions and a January 10, 2025 deadline for quote submissions, both at 10:00 AM EST.

The solicitation is unrestricted and not set aside for small businesses, with a North American Industry Classification System (NAICS) code of 325412 for Pharmaceutical Preparation Manufacturing. The estimated annual requirement is approximately 80 vials, to be delivered to the Corporal Michael J. Crescenz VA Medical Center located at 3900 Woodland Ave in Philadelphia, Pennsylvania. While specific budget or award values were not explicitly stated in the documents, the contract will cover radiopharmaceutical isotope procurement with provisions for full credit on returned unused doses. The contract includes requirements for bar code labeling compatible with nuclear medicine information systems and mandates that the supplier maintain comprehensive quality control procedures. The place of performance is specifically the Nuclear Medicine Department of the Philadelphia VA Medical Center, with delivery and service expectations clearly defined in the solicitation documents.